chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Patient was requested to wait 30 min post vaccination due to h/o reaction to morphine in the past.  She stated that she is not to take any opioid.  Approximately 10-15 min into her wait time she c/o tingling, hot feeling.  She was laid down in a treatment room.  BP 173/98. Pulse ox and pulse normal range.  After a few minutes of monitoring, she sat up and became nauseaus.  Her BP dropped to 130/84.  She was laid back down.  Dr. assessed patient.  He recommended Zofran for her nauseau.  RN gave her sublingual Zofran.  After about 30 minutes, her BP was 140/90, and she felt "stable".  She was assessed again by Dr. and released home.  Nurse contacte her by phone after she returned home.  She said she still "did not feel the best".  We recommended that she contact her PCP as soon as possible and go to the ER/Urgent Care if she developed any severe symptoms.  These were explained to her by the nurse.
Case previously recorded as MA2009-6272. Initial case report received from a health care professional on 25 NOV 2009. Twenty children younger than 04 years of age received FLUVIRIN influenza A intramuscular inadvertent administration on an unknown date. No adverse events reported. Medical: Not reported. Agency reference no. NA09-008851.
pt recv vax 12DEC96 & 29MAY97 pt devel couple of lesions;pt devel a few more 30MAY97;the reporter noted that this was a more attenuated case;f/u was recv which indicated pt was dx w/contact dermatitis not varicella;
Got first vaccine Jan 3 then diagnosed on Jan 21 positive, came home 54 days later. When is the 2nd dose needed. The doctor said 90 days. When do you get the 2nd dose after being positive; Got first vaccine Jan 3 then diagnosed on Jan 21 positive; Based on the current case data, this case has been classified as invalid. This spontaneous case was reported by a consumer and describes the occurrence of SARS-COV-2 TEST POSITIVE (Got first vaccine Jan 3 then diagnosed on Jan 21 positive) and PRODUCT DOSE OMISSION ISSUE (Got first vaccine Jan 3 then diagnosed on Jan 21 positive, came home 54 days later. When is the 2nd dose needed. The doctor said 90 days. When do you get the 2nd dose after being positive) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 03-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 21-Jan-2021, the patient experienced SARS-COV-2 TEST POSITIVE (Got first vaccine Jan 3 then diagnosed on Jan 21 positive). On an unknown date, the patient experienced PRODUCT DOSE OMISSION ISSUE (Got first vaccine Jan 3 then diagnosed on Jan 21 positive, came home 54 days later. When is the 2nd dose needed. The doctor said 90 days. When do you get the 2nd dose after being positive). At the time of the report, SARS-COV-2 TEST POSITIVE (Got first vaccine Jan 3 then diagnosed on Jan 21 positive) outcome was unknown and PRODUCT DOSE OMISSION ISSUE (Got first vaccine Jan 3 then diagnosed on Jan 21 positive, came home 54 days later. When is the 2nd dose needed. The doctor said 90 days. When do you get the 2nd dose after being positive) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medications were reported.  No treatment medications were reported.   Reporter did not allow further contact
Cough since receiving second dose of Pfizer Vaccine. Not constant, but about 5 times daily. It is a deep and dry cough, also unusual for patient.; This is a spontaneous report from a contactable consumer, the patient. A 17-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EF8731) via an unspecified route of administration in the left arm on 26Apr2021 at 09:45 (at the age of 17-years-old) as a single dose for COVID-19 immunisation. Medical history included COVID-19. The patient had no known allergies. Prior to vaccination, the patient was diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. The patient did not receive any other medication within two weeks of vaccination. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration on an unknown date as a single dose for COVID-19 immunisation. On 27Apr2021, since receiving the second dose of Pfizer vaccine, the patient experienced cough. Not constant, but about 5 times daily. It was a deep and dry cough, also unusual for the patient. The event did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. Therapeutic measures were not taken as a result of the event. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the event cough not constant, but about 5 times daily, deep and dry cough unusual for the patient was not resolved at the time of this report.  No follow-up attempts are needed. No further information is expected.
got my flu shot in oct tested positive for type b; Initial information received on 13-Jan-2023 regarding an unsolicited valid Social Media non-serious case received from a consumer/non-healthcare professional.  This case involves Adult and unknown gender patient who experienced got my flu shot in oct tested positive for type b after receiving vaccine INFLUENZA VACCINE.  The patient's past medical history, medical treatment(s), vaccination(s) and family history were not provided.   On an unknown date, the patient received a dose of suspect INFLUENZA VACCINE produced by unknown manufacturer (lot number, expiry date: not reported) via unknown route in unknown administration site (form, strength: unknown) for prophylactic vaccination.  On an unknown date the patient developed a non-serious event of got my flu shot in oct tested positive for type b (influenza) (unknown latency) following the administration of INFLUENZA VACCINE.  Action taken with INFLUENZA VACCINE was not applicable.  It was not reported if the patient received a corrective treatment for the event.  At time of reporting, the outcome was Unknown for the event.
Redness both arms 3-24-18. Redness with swelling and warmth on right arm on 3-25-18 also c/o pain in both knees starting 3-25-18. Today 3-26-18 large area about midnight of upper arm of redness and swelling in Rt upper arm with warmth to touch. Just mild redness left arm.
Within 5 minutes of receiving the vaccine patient had trouble controlling emotions - would laugh or cry inappropriately. Talking like a toddler, seemed clumsy. This lasted several hours - she was seen in the ER and had a normal exam and negative labs - returned to baseline.
Patient has a progressive dry cough and dyspnea on exertion that started a few days after receiving the second dose of the COVID vaccine.  He received a 10 day course of doxycycline for CAP as an outpatient without any improvement, hence he was admitted to the hospital for further workup.  CT scan was performed revealing findings concerning for ILD.  Of note a CT done in 2018 shows some possible early signs of ILD.  Pulmonology is seeing the patient and he was started on steroids today (3/17/2021).
typical Bell's Palsy; right side facial pain near the anterior right ear and traveling down the facial cranial nerve from that area to his jaw; right side facial pain near the anterior right ear and traveling down the facial cranial nerve from that area to his jaw; Weak feeling coming from the jaw; This is a spontaneous report from a non-contactable nurse (wife). A 38-year-old male patient (husband) received first dose of bnt162b2 (Pfizer-BioNTech COVID-19 mRNA vaccine, Lot Number EL3248 and Expiration Date unknown) via an unspecified route of administration on 19Jan2021 18:00 (vaccine location: left arm) at single dose for COVID-19 immunisation. The patient's medical history included hypogammaglobulinaemia, from years low IGA, chickenpox and shingles in the past. The concomitant medications were not reported. No history and additional vaccines administered on same date. On 20Jan2021 when patient woke up, right now at 09:21 AM, he noticed right side facial pain near the anterior right ear and traveling down the facial cranial nerve from that area to his jaw. Reporter stated this was typical Bell's Palsy and the usual treatment is the same as for herpes zoster; steroids and antivirals is the recommended treatment. Reporter is planning to call the doctor as she feels he needs treatment right away and she will get the doctor to prescribe this treatment. Patient has a weak feeling coming from the jaw. Patient had a history of chicken pox and chronic herpes zoster but this was the first time he had had Bell's Palsy. States the effects are persisting and medically significant. Patient was scheduled for the second dose 09Feb2021. Wanted to know about if patient should get the second dose of the vaccine. The outcome of events was not recovered.  No follow-up attempts are possible. No further information is expected.; Sender's Comments: A causal association between BNT162B2 and the reported events cannot be excluded based on a compatible temporal relation. The impact of this report on the benefit/risk profile of the Pfizer product is evaluated as part of Pfizer procedures for safety evaluation, including the review and analysis of aggregate data for adverse events. Any safety concern identified as part of this review, as well as any appropriate action in response, will be promptly notified to RAs, Ethics Committees, and Investigators, as appropriate.
Wouldn't walk/crawl that occured approx. 5 hours after immun.
Body aches; Nausea; Fever of 100; Very tired; Joint pain; This spontaneous case was reported by a consumer and describes the occurrence of MYALGIA (Body aches), NAUSEA (Nausea), PYREXIA (Fever of 100), FATIGUE (Very tired) and ARTHRALGIA (Joint pain) in a 69-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 010a21a) for COVID-19 vaccination.     No Medical History information was reported.    On 26-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 26-Feb-2021, the patient experienced MYALGIA (Body aches), NAUSEA (Nausea), PYREXIA (Fever of 100), FATIGUE (Very tired) and ARTHRALGIA (Joint pain). At the time of the report, MYALGIA (Body aches), NAUSEA (Nausea), PYREXIA (Fever of 100), FATIGUE (Very tired) and ARTHRALGIA (Joint pain) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Patient received first Moderna vaccine on 2-26-2021. Patient stated she had very severe side effects, body aches, nausea, 100 fever, very tired, joint pain, felt like herd of elephants went over her body.
Event #1: I experienced a small outbreak of hives on my left cheekbone within 15 minutes of receiving the vaccine. The staff gave me an injection of Benadryl into my right arm. The spot reduced in size over the duration of an hour and I was sent home with instructions to take OTC Benadryl until the swelling disappeared completely later that evening.  Event #2: Shortness of breath and chest tightness beginning exactly 74hrs after the vaccination (Sunday, 01/31/2021 at 2:15pm). This side-effect continues to persist and is  not due to a true Covid-19 infection.
This spontaneous report as received from a healthcare worker refers to a 12 month old male patient with no pertinent medical history and drug reactions/allergies. On 23-SEP-2013 the patient was vaccinated with dose 1, 0.5 milliliter (ml) of VARIVAX (Merck) (lot # H018782, expiration date 15-OCT-2014) subcutaneously. The patient's mother reported to the office the next day (24-SEP-2013) that the patient had few lesions on his chest. The physician came on the line and described the rash as a "classic" varicella like rash. She stated the patient had 20 lesions on his trunk, and 5 lesions on his lower extremities. She stated that the only treatment she recommended was calamine lotion for itching. No treatment was given for the "classic varicella-like rash" event. No lab diagnostic studies were performed for the event. Patient sought medical attention by office visit. The events did not resolve at the time of this report. Additional information is not expected.
Patient received Moderna Covid-19 vaccine from a freezer where the temperature had not been checked each day since April 13, 2023; No Adverse Event; This spontaneous case was reported by an other health care professional and describes the occurrence of PRODUCT STORAGE ERROR (Patient received Moderna Covid-19 vaccine from a freezer where the temperature had not been checked each day since April 13, 2023) and NO ADVERSE EVENT (No Adverse Event) in a 16-month-old female patient who received mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (batch no. 215K22A) for COVID-19 prophylaxis.     It was unknown whether patient received any other vaccine 4 weeks prior to COVID-19 vaccine.     On 28-Apr-2023, the patient received third dose of mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (unknown route) 1 dosage form. On an unknown date, the patient experienced PRODUCT STORAGE ERROR (Patient received Moderna Covid-19 vaccine from a freezer where the temperature had not been checked each day since April 13, 2023) and NO ADVERSE EVENT (No Adverse Event). At the time of the report, PRODUCT STORAGE ERROR (Patient received Moderna Covid-19 vaccine from a freezer where the temperature had not been checked each day since April 13, 2023) and NO ADVERSE EVENT (No Adverse Event) outcome was unknown.        For mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (Unknown), the reporter considered NO ADVERSE EVENT (No Adverse Event) to be not related. No further causality assessment was provided for PRODUCT STORAGE ERROR (Patient received Moderna Covid-19 vaccine from a freezer where the temperature had not been checked each day since April 13, 2023).    No concomitant medications was reported. No treatment drug details was reported. It was reported that the patient received first dose of the Moderna Covid-19 vaccine on 26-June-2022 lot number and expiration date, site of vaccination was not known. No Adverse Reactions was reported. Received second dose of the Moderna Covid-19 vaccine on 26-jul-2022, lot number and expiration date, site of vaccination was not known. No adverse reactions were reported. No other adverse reactions were reported for booster dose as well. Patient received Moderna Covid-19 vaccine from a freezer where the temperature had not been checked each day since April 13, 2023. It was not believed that the freezer had not gone out of range during that time however it was also not known if the freezer went out of range during that time. The freezer does have an alarm on it that has not gone off since April 13, 2023.
Shingles; This is a spontaneous report from a non-contactable consumer (daughter). A male patient of an unspecified age received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection), dose 1 via an unspecified route of administration in Jan2021 (Batch/Lot number was not reported) as single dose for covid-19 immunisation. The patient's medical history and concomitant medications were not reported. The patient got the first Pfizer vaccines the very end of Jan and he's due for the second vaccine this Saturday and he's developed shingles in 2021. The reporter wanted to know if the patient can get the second vaccine. The outcome of the event was unknown.  No follow-up attempts are possible. Information about lot/batch number cannot be obtained.
Patient was laying down in exam room for immunizations. 1st injection MMR given s/p RA without incident. Upon 2nd immuniz. Hep B, RA, pt. became unresponsive, unarousable, eyes rolled back, became very pale and dry, pt. sat up, turned very red, laid back down and began widespread shaking of entire body, legs, arms. Stiffened limbs, then started to arouse. This lasted approx 2-3 minutes.
8/27 2:40 pm: numbness/pins and needles sensation in bilateral feet 8/27 2:50 pm: numbness/pins and needles sensation moves up legs to just above ankles/mid-calf 8/27 2:55 pm: numbness/pins and needles sensation  into left side of neck 8/28 1:00 am: cold chills and fever, numbness still occurring in feet and hands 8/28 10:00 am: limited numbness in feet and hands which had improved but lasted all day. 8/29: woke up with pins and needles sensation in legs 8/31: pins and needles sensation spread to entire body 9/1-9/29: constant, pricking feeling all over body, stabbing feeling  more than 50 times per day 9/10:  left shoulder/chest aches 9/23: After laying on MRI table for 45 minutes, patient states he could not feel his lower body and had to be helped off the table.
significant headache; tested positive of COVID-19; This is a spontaneous report from a contactable consumer (physician Assistant) reporting for her husband.   A male patient of an unspecified age received bnt162b2 (BNT162B2), dose 1 via an unspecified route of administration on 22Apr2021 (Batch/Lot number was not reported) as single dose at an unknown age for COVID-19 immunisation.  The patient medical history and concomitant medications were not reported.  The patient was tested positive of COVID-19 in Apr2021 after vaccination, significant headache on 22Apr2021. The event tested positive of COVID-19 was considered medically significant. The patient underwent lab tests and procedures which included Sars-cov-2 test: positive in Apr2021, his test results (both rapid and PCR) confirmed positive. The course of events was as follows: her husband received his first dose of the Pfizer vaccine Thursday 22Apr2021 and developed a significant headache. Friday a.m. 23Apr2021 as he still had a headache the reporter asked for him to get a screening COVID test to make sure it was only a response to the vaccine and not something more serious. They were very surprised when his test results (both rapid and PCR) confirmed positive. The outcome of events was unknown.  Information about the Lot/batch number has been requested.
Pain during movements, putting on belt, jacket, sleeping and pain increases with use.  Trying to use it and work thru the pain.  Still having pain and don't know what to do.  Needle high in arm, never had such a problem.
Shivering uncontrollably for 2 to 2 and half hours; This spontaneous case was reported by a consumer and describes the occurrence of CHILLS (Shivering uncontrollably for 2 to 2 and half hours) in a 76-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 017C21A) for COVID-19 vaccination.     Concomitant products included OMEPRAZOLE, BIFIDOBACTERIUM LACTIS, BIFIDOBACTERIUM LONGUM, LACTOBACILLUS ACIDOPHILUS (FLORAJEN 3), DOCUSATE SODIUM (STOOL SOFTENER), CALCIUM CARBONATE, COLECALCIFEROL (VITAMIN D 2000) and ASCORBIC ACID (VITAMIIN C) for an unknown indication.    On 12-Jul-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 13-Jul-2021, the patient experienced CHILLS (Shivering uncontrollably for 2 to 2 and half hours). At the time of the report, CHILLS (Shivering uncontrollably for 2 to 2 and half hours) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Most recent FOLLOW-UP information incorporated above includes: On 28-Jul-2021: Follow-up information  received and contains non-significant information.
Child was taken to doctor due to a rash on upper right leg, that progressed to right hip and back. Rash was diagnosed as shingled (herpes Zoster) and child started on Acyclovir 4.5 mg PO every 8 hours - per parent report.
This spontaneous case reported by a consumer, describes the occurrence of vaccination site erythema (patient reports red patch on her arm on injected site looks like a bug bite) in a female patient, of an unknown age, who received mRNA-1273 (Moderna COVID-19 vaccine) for COVID-19 immunization. No medical history reported. On Mar 26, 2021, patient received the first dose of mRNA-1273 (Moderna COVID-19 vaccine), intramuscular; .5 milliliter. On Apr 3, 2021, patient experienced vaccination site erythema (patient reports red patch on her arm on injected site that looks like a bug bite). The patient treated with hydrocortisone, at an unspecified dose and frequency. At the time of the report, vaccination site erythema (patient reports red patch on her arm on injected site looks like a bug bite) outcome: unknown/not provided. The action taken with mRNA-1273 (Moderna COVID-19 vaccine), intramuscular: unknown. No concomitant medications provided.
pt recv vax 28MAR97 & 29MAR97 pt exp inguinal itching;30MAR97 pt devel papular, erythematous, pruritic dermatitis consisting of  fine, papular, pruritic eruptions;pt recovered;
This case was reported by a nurse via sales rep and described the occurrence of pain in arm in a 66-year-old female patient who received SHINGRIX for prophylaxis. On 23rd October 2018, the patient received SHINGRIX. On 23rd October 2018, less than a day after receiving SHINGRIX, the patient experienced pain in arm. On an unknown date, the outcome of the pain in arm was unknown. It was unknown if the reporter considered the pain in arm to be related to SHINGRIX. Additional details were provided as follows: The reporter reported that the patient went to the pharmacy but reported back to the physician's office that the vaccine looked dark in color and then after the injection was given, her arm hurt. The physician's office did not give SHINGRIX vaccines at their location and send patients to their retail pharmacy. The confirmation was received from QA team that there was no product quality issue.
Patient woke up in the morning to swelling of the entire face, around the eyes as well. Was given a dose of Benadryl and a cool compress to face and eyes. Swelling subsided and face returned to normal.
5 days after no symptoms all of a sudden many symptoms in March 7 8 9 101.3 fever fluctuated to 99 98 97 back to 99 on 7th day Nausea aches myslgias Severe chills overnight March 9 4 am Slight cough producing phlegm yellowish
ARM PAIN; This spontaneous report received from a patient by concerned a 7 decade old female. The patient's weight was 99.1 kilograms, and height was not reported. No past medical history or concurrent conditions were reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin, and batch number were not reported) dose, start therapy date were not reported for prophylactic vaccination. The batch number was not reported. The company is unable to perform follow-up to request batch/lot numbers. Concomitant medications included diphenhydramine hydrochloride, and riociguat. On an unspecified date, the patient experienced arm pain. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The outcome of arm pain was not reported. This report was non-serious.
Fussy after shots, parent reports fever but no temperature taken.  Reports Tylenol given but no relief.  Will take to Emergency Room for evaluation.  Also reports headache and stuffy nose.  Parent reports will call back with update.  6/18:  parent did not return call.   Unable to reach for more info.
Migraine - started 4 days after receiving vaccine (received vaccine on 4/2/21; migraine started 4/6/21). My migraines occur every 30-40 days ... this migraine started 12 days after my last migraine. In addition to the first early migraine after my first dose of the Moderna COVID-19 vaccine, I had a second migraine between my first and second doses of the Moderna COVID-19 vaccine. This was followed by a third migraine after my second dose of the Moderna COVID-19 vaccine.